C16ORF72/TAPR1 is also a target of miR‐134, a microRNA associated with tumorigenesis and chemo‐resistance (Shuang et al., 2015), and is associated with rare de novo CNVs in autism spectrum disorder (ASD) and schizophrenia (Levinson et al., 2011; Sanders et al., 2011). The gene discussed is HAPSTR1; the disease is autism spectrum disorder.